TRIM8 and non-small cell lung carcinoma: Moreover, all hazard ratios (HRs) of the univariate Cox regression analysis of the mRNA expression levels indicated the protective role of TRIM8 in the clinical outcomes of patients with NSCLC, except for patients with stage I lung squamous cell carcinoma.